Tianyi Jiang - 16 Mar 2026 Form 4 Insider Report for AvePoint, Inc. (AVPT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: AVPT
Reported as of: 16 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Mar 2026, 20:50:47 UTC
Prior SEC filing: 17 Mar 2026
Next SEC filing: 24 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Michael Brown, Attorney-in-Fact

Key filing fact

Tianyi Jiang filed Form 4 for AvePoint, Inc. (AVPT) on 18 Mar 2026.

Key facts

This page summarizes Tianyi Jiang's Form 4 filing for AvePoint, Inc. (AVPT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 20:50.

Change

Previous filing in this sequence was filed on 17 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001865596 Primary reporting owner

Jiang Tianyi

Relationship: Chief Executive Officer, Director
Address: C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY
Signature: /s/ Brian Michael Brown, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVPT transaction

Common Stock

Award

Transaction value
Shares: +147,338
Change %: +6.8%
Price: $0.000000^*
Shares after: 2,299,627
Date: 16 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVPT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +252,609
Change %: +10%
Price: $10.52^*
Shares after: 2,756,670
Date: 16 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 252,609
Exercise price: $10.52
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

Footnote F2

Represents performance-based RSUs ("PRSUs") based upon two metrics: Annual recurring revenue compounded annual growth rate for the years 2026-2028 (70% weighted) and FY 2028 GAAP profitability (30% weighted). Actual payouts may represent 50% to 200% of granted value. These PRSUs will fully vest upon certification of the actual payouts by the Issuer's Compensation Committee after the performance period ends.

Footnote F3

Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, and March 18, 2025.

Footnote F4

This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock.

Footnote F5

25% of the shares underlying these options will vest on March 16, 2027, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.